Delivery Order SPE2DB24D2205-SPE2DB25FEGWW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,146.43 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement fulfilled by AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $5,479.67 to AmerisourceBergen Drug Corp for Dexcom G7 Sensors on August 14, 2025, with a completion date of August 15, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,062.40 for Dexcom G7 sensors on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and is scheduled for completion by August 8, 2025. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.97 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor and healthcare solutions provider. The contract will be performed at the awardee's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,845.71. This firm fixed-price contract, executed on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGWWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,722.28 to AmerisourceBergen Drug Corp for Dexcom G7 Sensors on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dexcom G7 Sensors represent a specialized medical device component used in continuous glucose monitoring systems, supporting diabetes management for military personnel and beneficiaries within the Defense Health Agency system. AmerisourceBergen's position as a prime pharmaceutical vendor for the DLA reflects its established capability to fulfill federal medical supply requirements for military healthcare systems. The contract award demonstrates the DLA's ongoing reliance on this major pharmaceutical distributor to deliver critical medical commodities and specialized healthcare products that support operational readiness and personnel health across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/27/25 |